Gemcitabine plus Oxaliplatin (GEMOXI): a feasible treatment in elderly patients with advanced pancreatic cancer

被引：0
|
作者：
Corradini, G. M. [1 ]
Candido, P. [1 ]
Della Torre, S. [1 ]
Zannier, F. [1 ]
Cozzi, C. [1 ]
Belloni, P. [1 ]
Toniolo, D. [1 ]
Bollina, R. [1 ]
Tagliaferro, G. [1 ]
机构：
[1] Azienda Osped G Salvini, Div Med Oncol, Rho, Italy
来源：
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY | 2009年 / 72卷
关键词：
D O I：
10.1016/S1040-8428(09)70146-5
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S56 / S57
页数：2
相关论文
共 50 条
  • [41] Gemcitabine plus S-1: a hopeful frontline treatment for Asian patients with unresectable advanced pancreatic cancer
    Cao, Chunxiang
    Kuang, Meng
    Xu, Wei
    Zhang, Xunlei
    Chen, Jinfei
    Tang, Cuiju
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2015, 45 (12) : 1122 - 1130
  • [42] Efficacy of prophylactic minocycline treatment for skin toxicities induced by erlotinib plus gemcitabine in advanced pancreatic cancer patients
    Shinohara, Akira
    Okuyama, Hiroyuki
    Kuwahara, Akiko
    Kobayashi, Misaki
    Takahashi, Hideaki
    Ohno, Izumi
    Shimizu, Satoshi
    Mitsunaga, Shuichi
    Saitoh, Shinichiro
    Ikeda, Masafumi
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (03)
  • [43] Survival of patients with advanced pancreatic cancer is increased by nab-paclitaxel plus gemcitabine
    Nature Reviews Gastroenterology & Hepatology, 2013, 10 (12) : 695 - 695
  • [44] Curcumin and Gemcitabine in Patients With Advanced Pancreatic Cancer
    Epelbaum, Ron
    Schaffer, Moshe
    Vizel, Bella
    Badmaev, Vladimir
    Bar-Sela, Gil
    NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 2010, 62 (08): : 1137 - 1141
  • [45] A phase II trial of gemcitabine and erlotinib followed by ChemoProton therapy plus capecitabine and oxaliplatin for locally advanced pancreatic cancer
    Sanghvi, Samrat M.
    Coffman, Alex R.
    Hsueh, Chung-Tsen
    Kang, Joseph
    Park, Annie
    Solomon, Naveenraj L.
    Garberoglio, Carlos A.
    Reeves, Mark E.
    Slater, Jerry D.
    Yang, Gary Y.
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2022, : 1989 - 1996
  • [46] Predictors of vulnerability to nab-paclitaxel plus gemcitabine in patients with advanced pancreatic cancer
    Iede, Kiyotsugu
    Yamada, Terumasa
    Tominaga, Shusei
    ANNALS OF ONCOLOGY, 2023, 34 : S1453 - S1453
  • [47] The efficacy of capecitabine plus oxaliplatin combination chemotherapy for advanced pancreatic cancer after failed with gemcitabine-based therapy
    Ryu, Ji Kon
    Jung, Kwang Hyun
    Kim, Yong-Tae
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2016, 31 : 239 - 239
  • [48] TOXICITY STUDY OF GEMCITABINE, OXALIPLATIN AND BEVACIZUMAB THEN 5-FLUOROURACIL, OXALIPLATIN, BEVACIZUMAB AND RADIOTHERAPY IN PATIENTS WITH LOCALLY ADVANCED PANCREATIC CANCER
    O'Dwyer, P. J.
    Sun, W.
    Harlacker, K.
    Giantonio, B.
    Rosato, E.
    Ginsberg, G.
    Kochman, M.
    Drebin, J.
    Metz, J.
    ANNALS OF ONCOLOGY, 2010, 21 : 44 - 44
  • [49] Cisplatin/gemcitabine or oxaliplatin/gemcitabine in the treatment of advanced biliary tract cancer: a systematic review
    Fiteni, Frederic
    Nguyen, Thierry
    Vernerey, Dewi
    Paillard, Marie-Justine
    Kim, Stefano
    Demarchi, Martin
    Fein, Francine
    Borg, Christophe
    Bonnetain, Franck
    Pivot, Xavier
    CANCER MEDICINE, 2014, 3 (06): : 1502 - 1511
  • [50] Experience of Gemcitabine plus Oxaliplatin Chemotherapy in Patients with Advanced Biliary Tract Carcinoma
    Hollebecque, Antoine
    Bouche, Olivier
    Romano, Olivier
    Scaglia, Elodie
    Cattan, Stephane
    Zerbib, Philippe
    Heurgue, Alexandra
    Lagarde, Stephanie
    Mariette, Christophe
    Triboulet, Jean-Pierre
    Pruvot, Francois-Rene
    Hebbar, Mohamed
    CHEMOTHERAPY, 2010, 56 (03) : 234 - 238
12345